All News #Library
Rare Diseases
Cour Pharma Gets Orphan Status For CNP-106 In Myasthenia Gravis
01 Oct 2025 //
GLOBENEWSWIRE
COUR Pharma Gains FDA Orphan Drug Status For CNP-104 In PBC
08 Jan 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support